Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Mylotarg

This product is the most expensive of its product family


Contraindicated
Reproductive toxicity in animals

Contraindicated
Mylotarg :
Type Medicine Authorised
Originator Biotech (Mylotarg)
Agent Droguerie Fattal
Distributor Droguerie Fattal
Laboratory Pfizer
Responsible Party Wyeth Pharmaceutical LLC
Origin U.S.A.
Manufacturer Wyeth Pharmaceuticals Inc
Origin U.S.A.
ATC L01XC05

Your comment will appear shortly after approval

Mylotarg :

Revision Date : 21/07/2022


Effect Frequency
Abdominal pain Very Common
Anaemia Very Common
Ascites Common
Blood alkaline phosphatase increased Common
Blood lactate dehydrogenase increased Very Common
Budd-Chiari syndrome Common
Chills Very Common
Constipation Very Common
Cystitis haemorrhagic Not known
Decreased appetite Very Common
Diarrhoea (Diarrhea) Very Common
Dyspepsia Common
Dyspnoea (dyspnea) Very Common
Erythema Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Gamma-GT increased Common
Haemorrhage Very Common
Headache Very Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Common
Hepatic function abnormal Common
Hepatomegaly Common
Hyperbilirubinaemia Very Common
Hyperglycaemia Very Common
Hypertension Very Common
Hypotension Very Common
Infection Very Common
Infusion related reaction Common
Interstitial pneumonia Common
Jaundice Common
Leucopenia (Leukopenia) Very Common
Lymphopenia Common
Multi-organ failure Common
Nausea Very Common
Neutropenia Very Common
Neutropenic colitis Common
Oedema Very Common
Oesophagitis Common
Pancytopenia Common
Pruritus Common
Pyrexia Very Common
Skin rash Very Common
Stomatitis Very Common
Tachycardia Very Common
Thrombocytopenia (Thrombopenia) Very Common
Transaminases increased Very Common
Tumour lysis syndrome Common
Venoocclusive liver disease Common
Vomiting Very Common

Different Units By MoH Code

Mylotarg  MoH 10226 :
Form Powder for concentrate for solution for infusion
Packaging Vial (Type I Glass)
Package Size 1+1x0.5ml
Package Content Amber Type 1 glass vial, with butyl rubber stopper and crimp seal with flip-off cap
Strength 4.5mg
Storage Condition 2-8°C Do not freeze
Public Price 13247916 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 17620/1
Submission date 29/01/2020
Registration Year 16/07/2020


Price Comparison

● Country: Abu Dhabi
● Package Size: 1 Vial
● Public Price: 41002.5 AED ( 990,661,402.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 41002,5 AED ( 990,649,322.00 LBP )
● Pharmacy Price: 34928.3 AED ( 843902656.3 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 1hgl
● Public Price: 1324269 ISK ( 854,153,505.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1324269 ISK ( 854,153,505.00 LBP )
● Pharmacy Price: 1059657 ISK ( 683478765 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Germany
● Package Size: 1
● Public Price: 8120.84 EUR ( 786,714,495.84 LBP )
● Pack size unit used: 1
● Cost/Unit: 8120,84 EUR ( 786,633,120.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 1
● Public Price: 7827.29 EUR ( 758,276,546.04 LBP )
● Pack size unit used: 1
● Cost/Unit: 7827,29 EUR ( 758,248,452.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 7632 EUR ( 739,357,632.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 7632 EUR ( 739,357,632.00 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for concentrate for solution for infusion
● Package Size: 1+1x0.5ml
● Public Price: 13247916 LBP ( 13,247,916.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 13247916 LBP ( 13,247,916.00 LBP )
● Pricing Date: 13/06/2024

● Country: Spain
● Package Size: 1 vial
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

De novo CD33-positive acute myeloid leukaemia : (Adults)
● Cost/Unit: 41002,5 AED ( 990,649,322.00 LBP )
● Cost/Day: AED ( 0.00 LBP )
● Cost/Month: AED ( 0.00 LBP )
De novo CD33-positive acute myeloid leukaemia : (Adults)
● Cost/Unit: 1324269 ISK ( 854,153,505.00 LBP )
● Cost/Day: ISK ( 0.00 LBP )
● Cost/Month: ISK ( 0.00 LBP )
De novo CD33-positive acute myeloid leukaemia : (Adults)
● Cost/Unit: 8120,84 EUR ( 786,633,120.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
De novo CD33-positive acute myeloid leukaemia : (Adults)
● Cost/Unit: 7827,29 EUR ( 758,248,452.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
De novo CD33-positive acute myeloid leukaemia : (Adults)
● Cost/Unit: 7632 EUR ( 739,357,632.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
De novo CD33-positive acute myeloid leukaemia : (Adults)
● Cost/Unit: 13247916 LBP ( 13,247,916.00 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info